Clinical trials
Testicular Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 8 |
| Recruiting | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical Research Council | 5 |
| Royal Marsden NHS Foundation Trust | 4 |
| Children's Cancer and Leukaemia Group | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| NHS Greater Glasgow and Clyde | 2 |
| Queen Mary University of London | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Cancer Research Campaign Clinical Trials Centre | 1 |
| Context Therapeutics Inc. | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Testicular Neoplasms | 26 |
| Ovarian Neoplasms | 9 |
| Teratoma | 9 |
| Seminoma | 8 |
| Endodermal Sinus Tumor | 7 |
| Carcinoma, Embryonal | 6 |
| Endometrial Neoplasms | 5 |
| Central Nervous System Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.